PropertyValue
?:abstract
  • Owing to the extended nature and worldwide exposure of the coronavirus disease (COVID-19) pandemic, it is likely that the presence and impact of behavioral health conditions will increase. For example, it is anticipated that individuals living with a major depressive disorder could reach as high as 60% of the population owing to the ongoing disruption from COVID-19. In 2017, the annual rate of individuals experiencing a major depressive episode was only 7.1%. Pharmacists, specifically community pharmacists, are well positioned to provide needed intervention and triage services to individuals living with, and struggling with, a mental health condition. Pharmacists, therefore, need additional training and support to be effective in serving the community in this way.
is ?:annotates of
?:creator
?:doi
  • 10.1016/j.japh.2020.11.010
?:doi
?:journal
  • J_Am_Pharm_Assoc_(2003)
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/60b4a038e26fe49a25257478eb1a97408e4228f7.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7720695.xml.json
?:pmcid
?:pmid
?:pmid
  • 33303338.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • A call to action: Community pharmacists to address COVID-19–related behavioral health concerns
?:type
?:year
  • 2020-12-07

Metadata

Anon_0  
expand all